콘텐츠로 건너뛰기
Merck
모든 사진(1)

Key Documents

View All Documentation

450960

Sigma-Aldrich

Lutetium(III) chloride

anhydrous, powder, 99.99% trace metals basis

동의어(들):

Lutetium chloride, Lutetium trichloride

로그인조직 및 계약 가격 보기
모든 사진(1)

About This Item

Linear Formula:
LuCl3
CAS Number:
10099-66-8
Molecular Weight:
281.33
EC Number:
233-240-1
MDL number:
MFCD00011099
UNSPSC 코드:
12352302
PubChem Substance ID:
24868595
NACRES:
NA.23

Grade

anhydrous

Quality Level

100

분석

99.99% trace metals basis

형태

powder

반응 적합성

reagent type: catalyst
core: lutetium

불순물

≤150.0 ppm Trace Rare Earth Analysis

mp

905 °C (lit.)

density

3.98 g/mL at 25 °C (lit.)

SMILES string

Cl[Lu](Cl)Cl

InChI

1S/3ClH.Lu/h3*1H;/q;;;+3/p-3

InChI key

AEDROEGYZIARPU-UHFFFAOYSA-K

애플리케이션

Lutetium(III) chloride can be used:
  • As a precursor to synthesize chiral bridged lutetium catalyst for asymmetric hydroamination.
  • As a starting material to prepare doped lutetium oxide nanophosphors.
  • To fabricate scintillation detectors such as lutetium aluminum garnet (LuAG).

Storage Class Code

11 - Combustible Solids

WGK

WGK 2

Flash Point (°F)

Not applicable

Flash Point (°C)

Not applicable

개인 보호 장비

dust mask type N95 (US), Eyeshields, Gloves

가장 최신 버전 중 하나를 선택하세요:

시험 성적서(COA)

Lot/Batch Number
MKCB0960V
MKBV8849V
MKBR4789V
MKAA0295
MKBQ5281V

적합한 버전을 찾을 수 없으신가요?

특정 버전이 필요한 경우 로트 번호나 배치 번호로 특정 인증서를 찾을 수 있습니다.

COA 검색

이 제품을 이미 가지고 계십니까?

문서 라이브러리에서 최근에 구매한 제품에 대한 문서를 찾아보세요.

문서 라이브러리 방문

Sanjay Kumar Saxena et al.
Cancer biotherapy & radiopharmaceuticals, 32(10), 364-370 (2017-12-22)
The primary objective of this investigation is the development of a strategy for the synthesis of polyhydroxamic acid (PHA)-grafted cellulose film, its characterization, and evaluation of its usefulness for the preparation of
Usha Pandey et al.
Cancer biotherapy & radiopharmaceuticals, 34(5), 306-315 (2019-06-13)
Background: Transarterial radioembolization (TARE) represents an effective targeted therapeutic option for hepatocellular carcinoma (HCC), a cancer with high mortality
Ana Santidrián et al.
Physical chemistry chemical physics : PCCP, 22(18), 10063-10075 (2020-04-28)
In the present work, the effect of doping on electronic properties in bulk purified and filled arc-discharge single-walled carbon nanotubes samples is studied for the first time by in situ Raman spectroelectrochemical method. A major challenge to turn the potential
Raffaella Rossin et al.
Molecular pharmaceutics, 11(9), 3090-3096 (2014-08-01)
Radioimmunotherapy (RIT) of solid tumors is hampered by low tumor-to-nontumor (T/NT) ratios of the radiolabeled monoclonal antibodies resulting in low tumor doses in patients. Pretargeting technologies can improve the effectiveness of RIT in cancer therapy by increasing this ratio. We
Sander M J van Duijnhoven et al.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 56(9), 1422-1428 (2015-07-15)
Radioimmunotherapy and nuclear imaging (immuno-PET/SPECT) of cancer with radiometal-labeled antibody fragments or peptides is hampered by low tumor-to-kidney ratios because of high renal radiometal retention. Therefore, we developed and evaluated a pretargeting strategy using click chemistry in vivo to reduce
모든 관련된 서류 보기

문서

The Rare Earth Crisis—The Supply/Demand Situation for 2010–2015

The rare earth elements impact nearly everyone in the world. All of the people living in advanced technological countries and almost all those living in third world countries utilize the rare earths in their everyday living—the car that one drives (gasoline is refined from oil using rare earth catalysts and catalytic converters reduce the polluting emissions from the automotive exhaust), watching the news on TV (the red and green colors in TV screens), the telephones and computers we use to communicate (the permanent magnets in speakers and disc drives), just to name a few examples.

자사의 과학자팀은 생명 과학, 재료 과학, 화학 합성, 크로마토그래피, 분석 및 기타 많은 영역을 포함한 모든 과학 분야에 경험이 있습니다..

고객지원팀으로 연락바랍니다.